Courage Capital Management adds Antares Pharma Inc (ATRS) to its portfolio

Antares Pharma Inc (ATRS) : Courage Capital Management added new position in Antares Pharma Inc during the most recent quarter end. The investment management firm now holds 450,000 shares of Antares Pharma Inc which is valued at $486,000 , the company said in a statement filed on Aug 12, 2016 with the SEC.Antares Pharma Inc makes up approximately 0.49% of Courage Capital Management’s portfolio.

Other Hedge Funds, Including , Citadel Advisors added ATRS to its portfolio by purchasing 31,570 company shares during the most recent quarter which is valued at $34,096.Blackrock Institutional Trust Company N.a. reduced its stake in ATRS by selling 1,282,202 shares or 31.26% in the most recent quarter. The Hedge Fund company now holds 2,820,119 shares of ATRS which is valued at $3,045,729. Blackrock Investment Management sold out all of its stake in ATRS during the most recent quarter. The investment firm sold 556,754 shares of ATRS which is valued $601,294.National Planning Corp boosted its stake in ATRS in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 64,333 shares of Antares Pharma Inc which is valued at $68,836. Antares Pharma Inc makes up approx 0.01% of National Planning Corp’s portfolio.California Public Employees Retirement System reduced its stake in ATRS by selling 10,000 shares or 3.03% in the most recent quarter. The Hedge Fund company now holds 320,500 shares of ATRS which is valued at $355,755.

Antares Pharma Inc closed down -0.23 points or -16.31% at $1.18 with 33,02,659 shares getting traded on Monday. Post opening the session at $1.37, the shares hit an intraday low of $1.16 and an intraday high of $1.37 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

Antares Pharma Inc. (Antares) is a specialty pharmaceutical Company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures for itself and with partners pressure-assisted injectors with and without needles which allow patients to self-inject drugs. It has developed variations of the needle-free injector by adding a small shielded needle to a pre-filled single-use disposable injector called the Vibex pressure assisted auto injection system. This system is an alternative to the needle-free system for use with injectable drugs in unit dose containers and is suitable for branded and generic injectables. It has also developed a disposable multi-dose pen injector for use with standard cartridges.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *